Embark Ventures
VC Fund
Los Angeles, United States
Embark Ventures is a pre-seed and seed stage fund focused on "deep tech" companies. We look for ambitious teams with break-through proprietary technology which provides a highly defensible competitive advantage in transforming multi-billion dollar industries.
- Total investments:
- 42
- Last investment:
- Lead investor:
- 7%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Embark Ventures invests in
Stages Embark Ventures invests in
Countries Embark Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Yipeng Zhao
|
|||
Investment Focus
Industry
- Biotechnology 6 (14%)
- Machine Learning 6 (14%)
- Artificial Intelligence 6 (14%)
- Robotics 3 (7%)
- Software 3 (7%)
Stage
- Seed 16 (38%)
- Series A 12 (29%)
- Series B 5 (12%)
- Pre-Seed 2 (5%)
- Series C 2 (5%)
Country
- United States 20 (48%)
- Canada 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Peter Lee
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 6 | Find email | |
|
Yipeng Zhao
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Via Separations
|
Via Separations is enabling industrial decarbonization with its novel chemistries that allow manufacturing facilities to slash their energy consumption while making more product. Targeting the 12% of US energy consumption that is wasted each year separating chemicals, Via reduces the load of the process by 90%, electrifies the mostenergy-intensive step in chemical production, and generates additional revenue for the customer. Today, Via is deploying its technology in pilot trials at pulp & paper facilities to eliminate 100 million metric tons of CO2 by 2050. Via’s innovation is a highly selective and robust membrane filter that replaces the energy-inefficient heat-based separations in industrial processes. Spun out of MIT’s Department of Material Science & Engineering, Via has scaled up the technology by more than 10 million times and demonstrated working prototypes at a commercial scale. | $36M / Venture - Series Unknown / Apr 01, 2026 | |
QSimulate
|
QSimulate is a simulation platform that solves pressing problems for the chemical and pharmaceutical industries. It aims to deliver best-time-to-solution algorithms to chemical and pharmaceutical industries to accelerate their computational R&D. It is headquartered in Cambridge, Massachusetts. | Seed / Nov 20, 2025 | |
TRIC Robotics
|
TRIC Robotics develops an autonomous, non-chemical pesticide alternative for strawberry farms. The company was founded in 2017 and is headquartered in Newark, DE. | $5.5M / Seed / Jul 23, 2025 | |
Izote Biosciences
|
Biomanufacturing Scale-Up Solution | $3.1M / Pre-Seed / Feb 01, 2025 | |
Elemind Technologies
|
Elemind Technologies is a neurotechnology company that shapes brainwaves and changes brain states using novel neuromodulation techniques. The company was founded in 2017 and has its headquarters in Cambridge, Massachusetts. | $12M / Seed / Feb 06, 2024 | |
Prosper
|
Prosper's offering includes fee-free investments in public market index funds, including fund fees, as well as SIPP and ISA wrappers. | $4M / Angel / Nov 06, 2023 | |
Machina Labs
|
Machina Labs is a mechanical & industrial engineering & manufacturing firm that unlocks manufacturing through AI & machine learning. | $32M / Series B / Oct 05, 2023 | |
CellFE
|
CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells. | $22M / Series A / Sep 27, 2023 | |
SafeAI
|
SafeAI retrofits heavy equipment for autonomous applications in the mining and construction industries. SafeAI autonomous technology enables equipment owners to transform existing machines into self-operating robotic assets | $38M / Series B / Dec 14, 2022 | |
Breeze Intelligence
|
We offer a range of products that build on a common infrastructure backbone to help different customers to quickly productize their ML tools and make effective use of their cloud resources. | $4M / Seed / Nov 05, 2022 | |
| See all 42 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Embark Ventures invest in?
Embark Ventures invests primarily in Biotechnology, Machine Learning and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 42 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Embark Ventures?
Public channels for Embark Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Embark Ventures?
The team at Embark Ventures includes Peter Lee (Co-Founder and Managing Partner) and Yipeng Zhao (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
